收藏 分享
收录年代
序号 标题 作者 起始页 操作
1 It's time to pass the baton Karlan, Beth Y. 445
2 Linking altered microRNA expression to racial disparities in uterine serous carcinoma Wei, Jian-Jun 446
3 Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement Harrison, R., Zighelboim... 448
4 MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma Lee, Larissa, Howitt... 453
5 Gemogenovatucel-T (Vigil) maintenance immunotherapy: 3-year survival benefit in homologous recombination proficient (HRP) ovarian cancer Walter, Adam, Rocconi... 459
6 Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer Hendrickson, A. E. Wahner, Davidson... 465
7 An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer Liu, Joyce, Burris... 473
8 A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer Manyam, Madhavi, Stephens... 481
9 Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancer Swisher, Elizabeth M., Kristeleit... 490
10 Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancers Azzalini, Eros, Barbazza... 498